PlainRecalls
FDA Drug Moderate Class II Ongoing

Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml Single Dose Vial, Rx only, Compounded drug by Medivant Healthcare, 158 S Kyrene Rd, Chandler, AZ 85226, NDC 81483-0038-0, UPC 3 81483 00380 2

Reported: July 17, 2024 Initiated: July 3, 2024 #D-0594-2024

Product Description

Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml Single Dose Vial, Rx only, Compounded drug by Medivant Healthcare, 158 S Kyrene Rd, Chandler, AZ 85226, NDC 81483-0038-0, UPC 3 81483 00380 2

Reason for Recall

Subpotent Drug: reduced efficacy for epinephrine

Details

Recalling Firm
TAILSTORM HEALTH INC
Units Affected
12,525 10 mL vials
Distribution
Nationwide in the USA
Location
Chandler, AZ

Frequently Asked Questions

What product was recalled?
Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml Single Dose Vial, Rx only, Compounded drug by Medivant Healthcare, 158 S Kyrene Rd, Chandler, AZ 85226, NDC 81483-0038-0, UPC 3 81483 00380 2. Recalled by TAILSTORM HEALTH INC. Units affected: 12,525 10 mL vials.
Why was this product recalled?
Subpotent Drug: reduced efficacy for epinephrine
Which agency issued this recall?
This recall was issued by the FDA Drug on July 17, 2024. Severity: Moderate. Recall number: D-0594-2024.